<?xml version="1.0" encoding="UTF-8"?>
<p>A controversial study performed by Gautret et al. with a small sample size demonstrated that HCQ (26) treatment daily at 600 mg significantly decreases viral load in COVID-19 patients and its effect is reinforced by azithromycin (AZ; 49) combination.
 <xref rid="B219" ref-type="bibr">
  <sup>219</sup>
 </xref> Until this moment there is clinical robustness to support AZ (49) therapy in COVID-19.
 <xref rid="B228" ref-type="bibr">
  <sup>228</sup>
 </xref>
</p>
